Search Results - "Wiesinger, B. A."

Multicenter, Open-Label, Randomized Study to Compare the Safety and Efficacy of Levofloxacin versus Ceftriaxone Sodium and Erythromycin Followed by Clarithromycin and Amoxicillin- Clavulanate in the Treatment of Serious Community-Acquired Pneumonia in Adults by Fogarty, C., Siami, G., Kohler, R., File, T. M., Tennenberg, A. M., Olson, W. H., Wiesinger, B. A., Scott Marshall, J.-A., Oross, M., Kahn, J. B.

“…This randomized, multicenter, phase IV, comparative trial, which was designed to show equivalence, compared the efficacy of levofloxacin with that of a…”
Get full text

Macrolide-Resistant Streptococcus pneumoniae in Community-Acquired Pneumonia: Clinical and Microbiological Outcomes for Patients Treated with Levofloxacin by Kahn, J. B., Wiesinger, B. A., Xiang, J.

“…The rapid emergence and increasing prevalence of antimicrobial resistance in Streptococcus pneumoniae have greatly complicated the choice of empirical…”
Get full text

Cumulative Clinical Trial Experience with Levofloxacin for Patients with Community-Acquired Pneumonia-Associated Pneumococcal Bacteremia by Kahn, J. B., Bahalr, N., Wiesinger, B. A., Xiang, J.

“…Streptococcus pneumoniae has been isolated in up to two-thirds of all cases of community-acquired pneumonia (CAP), and pneumococcal bacteremia has been…”
Get full text

Multicenter, Postmarketing Assessment of Levofloxacin in the Treatment of Adults with Community-Acquired Pneumonia by Akpunonu, B., Michaelis, J., Uy, C. N., Tennenberg, A. M., Wiesinger, B. A., Karim, R., Marshall, J. Scott, Kahn, J. B.

“…This phase IV, multicenter, open-label trial was designedto provide confirmation of the efficacy and safety of levofloxacin, 500 mg once daily, in a large…”
Get full text

A Multicenter, Investigator-Blinded, Randomized Comparison of Oral Levofloxacin and Oral Clarithromycin in the Treatment of Acute Bacterial Sinusitis by Adelglass, Jeffrey, Jones, Terry M., Ruoff, Gary, Kahn, James B., Wiesinger, Barbara A., Rielly-Gauvin, Katie, Siu, Cynthia O.

“…A multicenter, investigator‐blinded, randomized, parallel‐group study was conducted to compare oral levofloxacin 500 mg once/day for 14 days with…”
Get full text

A multicenter, open-label, randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia by Frank, Elliott, Liu, Jing, Kinasewitz, Gary, Moran, Gregory J., Oross, Margaret P., Olson, William H., Reichl, Veronica, Freitag, Susan, Bahal, Neelam, Wiesinger, Barbara A., Tennenberg, Alan, Kahn, James B.

“…Background: Changing etiologic patterns and the growing problem of antimicrobial resistance, particularly an increase in macrolide-resistant pneumococcal…”
Get full text

Macrolide-resistant Streptococcus pneumoniae in community-acquired pneumonia: Clinical and microbiological outcomes for patients treated with levofloxacin: Efficacy of levofloxacin for the treatment of community-acquired pneumonia and associated infections by KAHN, J. B, WIESINGER, B. A, XIANG, J

Get full text

Cumulative clinical trial experience with levofloxacin for patients with community-acquired pneumonia-associated pneumococcal bacteremia: Efficacy of levofloxacin for the treatment of community-acquired pneumonia and associated infections by KAHN, J. B, BAHAL, N, WIESINGER, B. A, XIANG, J

Get full text

High-Dose, Short-Course Levofloxacin for Community-Acquired Pneumonia: A New Treatment Paradigm by Dunbar, Lala M, Wunderink, Richard G, Habib, Michael P, Smith, Leon G, Tennenberg, Alan M, Khashab, Mohammed M, Wiesinger, Barbara A, Xiang, Jim X, Zadeikis, Neringa, Kahn, James B

“…Levofloxacin demonstrates concentration-dependent bactericidal activity most closely related to the pharmacodynamic parameters of the ratio of area under the…”
Get full text

Multicenter, open-label, randomized study to compare the safety and efficacy of levofloxacin versus ceftriaxone sodium and erythromycin followed by clarithromycin and amoxicillin-clavulanate in the treatment of serious community-acquired pneumonia in adults: Efficacy of levofloxacin for the treatment of community-acquired pneumonia and associated infections by FOGARTY, C, SIAMI, G, KOHLER, R, FILE, T. M, TENNENBERG, A. M, OLSON, W. H, WIESINGER, B. A, MARSHALL, J.-A. Scott, OROSS, M, KAHN, J. B

Get full text

Multicenter, postmarketing assessment of levofloxacin in the treatment of adults with community-acquired pneumonia: Efficacy of levofloxacin for the treatment of community-acquired pneumonia and associated infections by AKPUNONU, B, MICHAELIS, J, UY, C. N, TENNENBERG, A. M, WIESINGER, B. A, KARIM, R, MARSHALL, J. Scott, KAHN, J. B

Get full text

Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study by Bundrick, William, Heron, Sean P, Ray, Paul, Schiff, William M, Tennenberg, Alan M, Wiesinger, Barbara A, Wright, Pamela A, Wu, Shu-Chen, Zadeikis, Neringa, Kahn, James B

“…To compare the safety and efficacy of levofloxacin with that of ciprofloxacin for the treatment of chronic bacterial prostatitis. In a multicenter,…”
Get full text

Acute Community-Acquired Bacterial Sinusitis: The Value of Antimicrobial Treatment and the Natural History by Gwaltney, Jack M., Wiesinger, Barbara A., Patrie, James T.

“…Two areas of investigation were reviewed: (1) placebo-controlled trials of antimicrobial treatment involving patients with a clinical diagnosis of acute…”
Get full text